Navigation Links
Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
Date:1/3/2008

LANSING, Mich., Jan. 3 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that its net income for the second quarter of FY 2008, which ended Nov. 30, increased 34% from the previous year's second quarter. Adjusted for a 3-for-2 stock split, net income in the quarter rose to $0.22 per share, compared to the prior year's $0.17. Neogen's second quarter net income of $3,254,000 set another quarterly record for the 25-year-old company.

Year-to-date net income for the first six months of Neogen's 2008 fiscal year increased 30% to $6,265,000 from $4,832,000 in FY 2007, or to $0.42 per share in the current year from the prior year's $0.34. Second quarter revenues increased 23% to $27,210,000, also a quarterly record, compared to the prior year's $22,189,000. Year-to-date revenues rose 18% during the fiscal year's first half to $50,118,000 from FY 2007's $42,409,000.

The second quarter was the 59th consecutive profitable quarter from operations for the company, and the 63rd quarter of the past 68 quarters to show increased revenues as compared with the previous year.

"Those who have followed Neogen closely know of our goal to achieve $100 million in annual sales this year, and I'm pleased to report that we are half way there after the first six months," said James Herbert, Neogen's chief executive officer and chairman. "The quarter's revenue contributes to our record of compound annual growth of 19% for the past 15 years."

Neogen's ongoing efforts to control costs, improve productivity, and the results of economies of scale were evident in the second quarter. Operating income as a percentage of sales increased to 17.6% in the current quarter from the previous year's comparable quarter of 16.7%.
'/>"/>

SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Neogen Acquires Kane Enterprises
2. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
3. Neogen Acquires Assets of Rivard Instruments
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
...HAI On day four of Gov. Jim Doyle,s trade mission...gy and software company, signed two major agreemen...rship is expected to result in new investments wor...f new jobs in Wisconsin. , ,"This deal shows the t...nies to play a role as China is rapidly upgrading ...
... are three locations on an Internet search page: t...me fits onto a single page and other times its 100...: If your Web sites identity is successful, only t...le to potential customers. However, if its submerg...ysterious undercurrents or worse, rest at the bott...
...ON The national AFL-CIO has taken its Show on the...ing too many jobs overseas, the labor union organi... the Jobs . , ,Laid-off workers, students, a pries...mong the 51 people who toured Wisconsin and seven ...y the Bush administration to promote a growing eco...
...n on investment has become a national obsession. L...t. But in many organizations ROI has become more o...ot always clear who is in the drivers seat. Becaus... through organizations, squashing otherwise approp...of the way. Some organizations throw away the keys...
Other Biology Technology:Does your web site have visibility? 2Does your web site have visibility? 3Theres a surprising, and positive, side to the offshore jobs debate 2Theres a surprising, and positive, side to the offshore jobs debate 3Make ROI work for you 2Make ROI work for you 3
(Date:10/6/2008)...ELPHIA Moderate consumption of red wine may decre... report in the October issue of Cancer Epidemiolo...ican Association for Cancer Research. , "An ant...f lung cancer, particularly among smokers," said C...rmanente ,Department of Research and Evaluation i...
(Date:10/6/2008)... Hughes Medical Institute researchers have develop...ted Down syndrome and two other serious chromosoma...f confirmed in larger trials, they say, the test w...ive prenatal tests such as amniocentesis that pose...ong known that a pregnant woman,s blood contains s...
(Date:10/6/2008)...ne,s for the birds. , A study by biologists at Wa...re diverse a bird population is in an area, the le...us (WNV). , Now, let,s hear it for the birds. , ... species in your backyard, you have much lower ris...n, doctoral candidate in biology in Arts & Science...
(Date:10/6/2008)... What does a mixture of two different kinds of ce...? The same basic force causes both mixtures to sep...onclusion of a new three-dimensional computer mode...tson, assistant professor of physics at Vanderbilt...of Waterloo in Canada that is described in the Oct...
Breaking Biology News(10 mins):Red wine may lower lung cancer risk 2New blood test for Down syndrome 2New blood test for Down syndrome 3New blood test for Down syndrome 4Study: Bird diversity lessens human exposure to West Nile Virus 2Surface tension drives segregation within cell mixtures 2AMDL Updates Q2 and FY2008 Guidance 6883 1AMDL Updates Q2 and FY2008 Guidance 6883 2AMDL Updates Q2 and FY2008 Guidance 6883 3GKSS membranes reduce air pollution in Beijing 4306 1GKSS membranes reduce air pollution in Beijing 4306 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 1China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 3VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 2
... a newly marketed vaccine promises to drastically ... major cause of cervical cancer, a new discovery b...could some day help the millions of people already...d cancer. , One study found that 75 percent of sex...had, an HPV infection, while 10,000 women annually...
... flies, ability to discern one sex from another ma... of nerve cells, and the number of receptors is co... University of Illinois at Chicago researchers hav...ate, perceive and learn to debilitating illnesses ...strophy, post-traumatic stress syndrome and schizo...
...standing how the human brain learns to perceive ob...ience. In 2003, Pawan Sinha, a professor at the M...initiative with the hopes of shedding some light o...s "Project Prakash" is to find, treat, and study c...e study that resulted from this project appears in...
...tists at Queensland University of Technology are o... to protect women against contracting the most com...ernational vaccine company Sanofi-Pasteur has awar...ontinue its research into Chlamydia and work towar...lescent women. , Professor Peter Timms, from QU...
Other Biology News:Synthetic peptide targets latent papilloma virus infections 2Synthetic peptide targets latent papilloma virus infections 3Synthetic peptide targets latent papilloma virus infections 4Bisexual fruit flies show new role for neurochemical 2Chlamydia vaccine a step closer to reality 2
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C.
Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412
Homo sapiens MEP50 protein, mRNA
SeeDNA co-precipitant, 250 ul (125 precipitations). Vivid pink color ensures easy pellet location.Efficient precipitation maximizes nucleic acid recovery.Chemically inert, compatible with most molecu
Biology Products: